A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune response had a lower risk of Alzheimer’s and Parkinson’s disease.
Scientists at Oregon’s only public academic health center (OHSU) have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia.
A neuroradiologist at the Mayo Clinic in Jacksonville, FL warns that increased use of monoclonal antibody treatment for Alzheimer’s has also led to the discovery of amyloid-related imaging abnormalities — ARIA. Find out more.
Tau PET is an imaging test used to detect the presence of tau protein in the brain. Researchers say it’s the best way to predict the rate of cognitive decline due to Alzheimer’s.
Researchers at UCI found that breathing in aromas while sleeping sparks a 226% cognitive increase.
Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning” – the worsening of symptoms late in the day.
The future of millions at risk for dementia could change with the use of hearing aids. Learn more.
Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.
FREE 32-PAGE BOOK: Dementia design improves the independence of people with dementia. This online book is available at no charge. Learn dozens of clever design tips that can make a world of difference.
As long as you’re awake, take comfort in knowing that it is simply not possible to lose your memory completely. Learn about different types of memory, what types are affected by memory loss and which types are protected.
How far that little candle throws his beams! So shines a good deed on a weary world. William Shakespeare
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
